Keros Therapeutics, Inc.
CRYSTAL FORMS OF AN ALK2 INHIBITOR
Last updated:
Abstract:
The invention relates to crystalline forms of an ALK2 inhibitor, methods of their preparation, and related pharmaceutical preparations thereof. The invention also relates to pharmaceutical uses of the crystalline forms.
Status:
Application
Type:
Utility
Filling date:
23 Apr 2021
Issue date:
5 Aug 2021